Designing a Multimodal Treatment Plan

We have tracked down the man and dog of the hour.

Paul Conyngham and his dog Rosie gained worldwide attention over the past week for breaking new medical ground. Using a variety of artificial intelligence tools, Conyngham – and some doctors and scientists in Australia – managed to create a personalized (petalized?) cancer treatment for Rosie that appears to be working.

The story resonated with the public for a couple of big reasons. First off, Conyngham has no real science or biology background. He’s a longtime AI researcher who used things like ChatGPT, Gemini and Grok to give him a plan for how to attack Rosie’s untreatable cancer and then how to craft and shape a unique mRNA shot for his pup. This exercise demonstrated the powers of AI technology to aid all of us with extra knowledge and skills and just how far bio-tech has come in terms of new cancer therapies.

Most people have had their hearts warmed by the tale of Paul and Rosie. Dude’s dog is dying. Dude goes to great lengths to try and solve the problem. Dude and his dog seem to mark a major moment for AI and medicine.

Some other people on the internet, however, are less excited by the story. They argue that the AI tools did very little here and that the science isn’t terribly conclusive or ground-breaking. Companies like Moderna and BioNTech already have personalized cancer vaccine data in trials, and it looks good. Who cares if we did the same thing for a dog? Rosie has also been treated with chemotherapy drugs, so we don’t even know if the mRNA technology is really the thing shrinking her tumors. And so on.

You can find some of the major criticisms here and here.

Some of the pushback may be valid, although Conyngham isn’t having it – as you’ll hear in the episode. It also sort of misses the point of this story.

After talking to Conyngham, it’s clear enough to me that he used AI in some profound ways here and that what was done with Rosie is symbolic of a huge shift in medicine. Regulators better get ready because the tools now exist for people to do rather daring experimentation on their pets and themselves. People in dire circumstances and with some means are going to be pushing the boundaries of what’s possible on a regular basis.

Paul and Rosie hit a nerve because their journey bundled up some massive technological and societal shifts into a tidy narrative.

Anyway, come listen to Paul and have a peek at Rosie.

The Core Memory podcast is on all major platforms and on our YouTube channel over here. If you enjoy the show, please leave a review and tell your friends.

This podcast is sponsored by Brex, the intelligent finance platform built to help companies spend smarter and move faster.

We run on Brex and so should you. Learn more about Brex right here.

The podcast is also made possible by E1 Ventures, which backs the most ambitious founders and start-ups.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.corememory.com/subscribe